瑞士诺华的地拉罗司国内有吗

Desirox is the first oral iron displacer approved by the U.S. FDA for routine use in patients ≥2 years of age with chronic iron overload caused by blood transfusions. Desirox is an oral active chelating agent that is highly selective for iron (Fe3+). Desirox is a ligand with three protrusions that binds iron with high affinity in a 2:1 ratio.

The common starting dose of Desirox is 20 mg/(kg·d). If there is massive blood transfusion and the iron increase is >0.5 mg/(kg·d) or the iron load before treatment is high, the recommended dose of Deferasirox Desirox is 30 mg/(kg·d). If the iron increase is <0.3 mg/kg, 10-15 mg/(kg·d) is enough to control the disease. Desirox should be taken on an empty stomach 30 minutes before meals. Desirox should be completely dissolved in water or apple or orange juice.

Desirox is developed by Novartis of Switzerland. Novartis of Switzerland has always focused on the growth area of pharmaceutical and health care. It not only has innovative drugs, but also has a diversified business portfolio such as consumer health products to best meet the needs of patients and society. Is deferasirox from Novartis Switzerland available in China?

Novartis Desirox is currently on the market in China. To purchase Novartis Deferasirox Desirox, patients need to consult and purchase it at major domestic hospitals or pharmacies with a prescription issued by a doctor. Novartis's Desirox, which is launched in China, is an original drug and has a relatively high price. Medical Companion Travel understands that the price of Desirox, which is marketed abroad, is much cheaper in China. If patients want to know the specific price information of this drug, or want to purchase cost-effective Deferasirox Desirox overseas, they can consult with domestic reliable overseas medical service companies (such as Medical Companion Travel).

Recommended related hot articles: /newsDetail/93916.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.